A recent study showed that memantine, a medicine approved to treat moderate-to-severe Alzheimer’s, significantly slows cognitive decline and reduces the need for caregiving by 45.8 hours per month.
---
Reisberg, Barry, Rachelle Doody, Albrecht Stöffler, Frederick Schmitt, Steven Ferris, and Hans Jörg Möbius. "Memantine in Moderate-to-Severe Alzheimer s Disease". New England Journal of Medicine . Vol. 348, No. 14, pp. 1333-41. [ Permalink ] |